| 740 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Study Shows Flu Vaccination Prevents Significant Flu Illness, Doctor's Visits and Hospitalizations |
CDC Study Shows Flu Vaccination Prevents Significant Flu Illness, Doctor’s Visits and Hospitalizations |
| significant vaccine benefits | 0.323604 |
| CDC experts | 0.353985 |
| lowest number | 0.265292 |
| flu vaccines | 0.503655 |
| flu vaccination program | 0.700541 |
| flu vaccination | 0.940979 |
| observational studies | 0.270628 |
| U.S. flu vaccination | 0.572756 |
| fewer flu cases | 0.489268 |
| non-elderly adults | 0.263224 |
| new CDC model | 0.332142 |
| substantial health benefits | 0.311512 |
| 6-year period | 0.278639 |
| flu surveillance data | 0.521448 |
| flu-associated disease outcomes | 0.316504 |
| specific times | 0.267689 |
| possible reason | 0.263865 |
| age groups | 0.313815 |
| vaccine effectiveness | 0.274609 |
| medical visits | 0.395556 |
| H1N1 pandemic | 0.268253 |
| 2009 pandemic | 0.266679 |
| direct annual impact | 0.327989 |
| new model | 0.333586 |
| health benefits | 0.321126 |
|
| Better flu vaccines | 0.490337 |
| study | 0.274439 |
| United States | 0.595935 |
| flu-related medical visits | 0.346171 |
| specific populations | 0.266655 |
| flu vaccination coverage | 0.567414 |
| burden | 0.270875 |
| flu-related hospitalizations | 0.440218 |
| 2010-11 season | 0.269005 |
| potential flu cases | 0.502186 |
| public health benefit | 0.319181 |
| repeatable way | 0.271696 |
| annual flu vaccination | 0.649293 |
| public health | 0.329863 |
| effective flu vaccines | 0.480513 |
| CDC researchers | 0.282534 |
| flu cases | 0.697843 |
| vaccine coverage | 0.326006 |
| study authors | 0.263408 |
| greatest benefit | 0.262534 |
| milder flu activity | 0.492889 |
| public health benefits | 0.318482 |
| higher public awareness | 0.314555 |
| disproportionately large portion | 0.316476 |
|
CLICK HERE |
| 4453 |
Centers for Disease Control and Prevention |
Html |
en |
Stay Safe on the Water: National Safe Boating Week | CDC Features |
Wearing a life jacket can dramatically decrease your chances of drowning while boating. Learn more during National Safe Boating Week, May 21-27, 2011, and |
| properly-fitted life jackets | 0.65474 |
| Carbon Monoxide Poisoning | 0.592909 |
| safe operation | 0.449322 |
| local requirements | 0.444614 |
| free public service | 0.564253 |
| poisonous gas | 0.440632 |
| influence | 0.342599 |
| PFD | 0.338094 |
| VSC Program | 0.467215 |
| sufficient ventilation | 0.439425 |
| boat engines | 0.458382 |
| Power Squadron volunteer | 0.560029 |
| boat operators | 0.472196 |
| alcohol | 0.445788 |
| greater risk | 0.452432 |
| passengers | 0.384795 |
| seasickness | 0.335904 |
| CDC Resources | 0.450473 |
| web site | 0.581997 |
| carbon monoxide | 0.715711 |
| recreational boating fatalities | 0.775713 |
| drownings | 0.337802 |
| water | 0.349429 |
| drink | 0.333824 |
| internal combustion engines | 0.554665 |
|
| Vessel Safety Check | 0.75227 |
| child injury | 0.474006 |
| fitted life jackets | 0.62269 |
| education courses | 0.445815 |
| wonderful way | 0.459412 |
| parents | 0.353286 |
| United States | 0.621762 |
| operator error | 0.438054 |
| early stages | 0.434931 |
| Administrators Web site | 0.556754 |
| Guard-approved life jackets | 0.632037 |
| fatal boating incidents | 0.782039 |
| State Boating Law | 0.727073 |
| recreational boats | 0.444124 |
| life jackets | 0.910724 |
| personal flotation devices | 0.619845 |
| people | 0.37121 |
| National Association | 0.444453 |
| following resources | 0.439534 |
| motor generators | 0.436227 |
| External Resources | 0.443471 |
| U.S. Coast Guard | 0.555348 |
| stays fun | 0.463504 |
| life-saving role | 0.482264 |
|
CLICK HERE |
| 5310 |
Centers for Disease Control and Prevention |
Html |
null |
Tuberculosis (TB) Vaccination |
Tuberculosis (TB) vaccine info for parents, public, and health care professionals |
|
|
CLICK HERE |
| 7213 |
Centers for Disease Control and Prevention |
Html |
en |
Babesiosis Surveillance - 18 States, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| County-level incidence rates | 0.40424 |
| red blood cells | 0.350215 |
| blood donors | 0.455716 |
| CDC | 0.379605 |
| supplemental data | 0.417693 |
| Babesia parasites | 0.417625 |
| symptom onset | 0.571497 |
| Babesia microti–endemic states | 0.446754 |
| genus Babesia | 0.376904 |
| transfusion-associated cases | 0.368611 |
| public health authorities | 0.498772 |
| Babesia duncani IFA | 0.386371 |
| probable cases | 0.508515 |
| Babesia microti DNA | 0.387448 |
| clinically manifest cases | 0.348852 |
| treatable tickborne disease | 0.342106 |
| median age | 0.36743 |
| patients | 0.456664 |
| severe cases | 0.354007 |
| human babesiosis | 0.513699 |
| tickborne disease | 0.34526 |
| persons | 0.371263 |
| babesiosis surveillance | 0.558392 |
| Babesia infection | 0.621426 |
| Elizabeth A. Bosserman | 0.386089 |
|
| clinical manifestations | 0.385715 |
| reported cases | 0.385609 |
| standard case definition | 0.691593 |
| transfusion-associated babesiosis | 0.46717 |
| babesiosis CRF | 0.493896 |
| national babesiosis surveillance | 0.528689 |
| reportable condition | 0.34472 |
| Babesia species | 0.359346 |
| Babesia spp. | 0.343576 |
| health departments | 0.425322 |
| intraerythrocytic Babesia organisms | 0.385226 |
| polymerase chain reaction | 0.403672 |
| Babesia laboratory data | 0.441714 |
| New York | 0.369902 |
| blood transfusion | 0.358182 |
| B. microti–endemic states | 0.426767 |
| cases | 0.772537 |
| babesiosis | 0.910398 |
| standard data collection | 0.348326 |
| symptom onset dates | 0.54017 |
| evidence-based prevention | 0.435156 |
| control measures | 0.432429 |
| Babesia microti immunoblot | 0.389178 |
| Ongoing national surveillance | 0.480742 |
|
CLICK HERE |
| 7290 |
Centers for Disease Control and Prevention |
Html |
en |
Fact Sheets - Physical Activity |
Physical Activity factsheets. |
| future service members | 0.803634 |
| Active People | 0.636435 |
| CDC | 0.456161 |
| goal | 0.443624 |
| Healthy Nation | 0.680597 |
| lives | 0.443505 |
| Builds | 0.440317 |
| better health | 0.589758 |
| effects obesity | 0.629006 |
| Americans | 0.50942 |
|
| healthy eating | 0.657362 |
| Better HealthFind | 0.607019 |
| economy | 0.441856 |
| Strong AmericaThis | 0.612289 |
| physical activity | 0.994679 |
| national initiative | 0.649362 |
| community benefits | 0.602386 |
| PDF-1.37MB] | 0.659103 |
| performance benefits | 0.612628 |
| military readiness | 0.822582 |
|
CLICK HERE |
| 10691 |
Centers for Disease Control and Prevention |
Html |
en |
Secondary Analysis Reports'Research' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 13879 |
Centers for Disease Control and Prevention |
Html |
en |
Resources & Publications |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| CDC | 0.661058 |
| Birth Defects | 0.653441 |
| Microsoft Word file | 0.62557 |
| Zika Virus Infection | 0.788819 |
| Zika Guidance Guidance | 0.731759 |
| Zika Test Specimens | 0.709925 |
| Congenital Microcephaly Case | 0.625713 |
| Pregnant Women | 0.67377 |
| Zika Virus Test | 0.797969 |
| Zika Reports | 0.652384 |
| ) Zika Spotlight | 0.697119 |
| page options Skip | 0.637376 |
| Surveillance Zika Cases | 0.716315 |
| Zika All Countries | 0.666556 |
| Congenital Zika Syndrome | 0.796394 |
| Email Address Enter | 0.717887 |
| CDC Activities | 0.637129 |
| Zika Virus Response | 0.783102 |
| Information Management Research | 0.623948 |
| FDA Zika Virus | 0.774769 |
| Address Enter Email | 0.717867 |
| Infectious Diseases | 0.692907 |
| Local Health Departments | 0.625135 |
| CDC A-Z | 0.652604 |
|
| Pregnancy Pregnant Women | 0.635701 |
| Zika Vector Control | 0.725981 |
| email address | 0.74429 |
| Zika Virus Resource | 0.823054 |
| Search Form Controls | 0.739867 |
| Children Zika | 0.661796 |
| zika virus | 0.995056 |
| Transmission Zika | 0.667432 |
| Enter Email Address | 0.717846 |
| Sexual Transmission | 0.661584 |
| Lancet Zika Virus | 0.780953 |
| Congenital Zika Infection | 0.722191 |
| Latest Zika Research | 0.69679 |
| Health Information Resource | 0.642506 |
| Search Controls | 0.639758 |
| CDC Deployments | 0.6384 |
| Zika Virus Research | 0.782945 |
| Zika Overview | 0.673993 |
| Zika Information Collections | 0.718679 |
| Zika Prevention Kit | 0.73009 |
| Zika Widgets | 0.65706 |
| Additional Resources | 0.6348 |
| Email Updates | 0.627786 |
| Elsevier Zika Virus | 0.778353 |
|
CLICK HERE |
| 14618 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for Interpretation of Zika Virus AntibodyTest Results | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| flavivirus infection | 0.318859 |
| IgM antibody result | 0.3147 |
| Zika virus | 0.931279 |
| recent flavivirus infection | 0.315868 |
| Zika virus–specific IgM | 0.316171 |
| recent Zika virus | 0.470597 |
| pregnant women | 0.313812 |
| virus neuroinvasive disease | 0.323613 |
| anti-Zika virus IgM | 0.365682 |
| plaque reduction neutralization | 0.329373 |
| flavivirus | 0.321141 |
| Zika virus exposure | 0.33347 |
| dengue virus | 0.502612 |
| dengue virus infections | 0.387717 |
| ongoing Zika virus | 0.334996 |
| possible adverse pregnancy | 0.322783 |
| Zika virus disease | 0.533883 |
| negative rRT-PCR result | 0.316502 |
| virus IgM ELISA | 0.36597 |
| virus IgM antibodies | 0.423574 |
| igm antibody | 0.413656 |
| reduction neutralization test | 0.326376 |
| transcription–polymerase chain reaction | 0.331239 |
| single-stranded RNA virus | 0.325803 |
|
| reverse transcription–polymerase chain | 0.330844 |
| Zika virus transmission | 0.350261 |
| specific infecting virus | 0.415427 |
| illness onset | 0.334648 |
| clinically suspected dengue | 0.357907 |
| adverse pregnancy outcomes | 0.32318 |
| real-time reverse transcription–polymerase | 0.33085 |
| Zika virus infection | 0.792943 |
| serum IgM antibody | 0.313091 |
| Zika IgM Antibody | 0.335074 |
| anti-Zika virus antibodies | 0.390024 |
| additional recent Zika | 0.313712 |
| dengue virus share | 0.359421 |
| Zika virus antibody | 0.409964 |
| virus IgM antibody | 0.380936 |
| Zika virus infections | 0.39756 |
| dengue virus infection | 0.369299 |
| dengue virus testing | 0.368053 |
| negative IgM antibody | 0.349748 |
| Zika virus IgM | 0.424965 |
| West Nile virus | 0.341482 |
| enzyme-linked immunosorbent assay | 0.323383 |
| Zika virus pregnancy | 0.358152 |
| local Zika virus | 0.336506 |
|
CLICK HERE |
| 15905 |
Centers for Disease Control and Prevention |
Html |
en |
September is World Alzheimer's Month | CDC Features |
When is memory loss more than forgetfulness? Learn more about Alzheimer's disease. |
| better diagnostic tests | 0.424202 |
| treatment | 0.225422 |
| early stages | 0.47152 |
| health care provider | 0.758524 |
| Alzheimer’s disease | 0.986895 |
| medical issues | 0.33354 |
| facts | 0.225459 |
| interactions | 0.226347 |
| skills | 0.225687 |
| memory problems | 0.329823 |
| medications | 0.255862 |
| disease affects | 0.333459 |
| behavioral changes | 0.319615 |
| treatable conditions | 0.349916 |
| addition | 0.227079 |
| family members | 0.319184 |
|
| warning signs | 0.449402 |
| treatable causes | 0.331185 |
| words | 0.22894 |
| certain sign | 0.322642 |
| concerns | 0.25151 |
| families | 0.225344 |
| people | 0.225366 |
| friends | 0.225362 |
| early diagnosis | 0.31681 |
| symptoms | 0.316389 |
| names | 0.228925 |
| measure | 0.226398 |
| person | 0.261618 |
| memory loss | 0.736247 |
| brain changes | 0.345641 |
| single test | 0.331943 |
|
CLICK HERE |
| 16242 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Poliomyelitis Eradication - Pakistan,January 2015-September 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| high-risk areas | 0.487945 |
| supplementary immunization activities | 0.433829 |
| environmental surveillance | 0.734954 |
| polio eradication | 0.47638 |
| independent WPV1 transmission | 0.451812 |
| WPV1 response efforts | 0.438043 |
| oral poliovirus vaccine | 0.695786 |
| endemic wild poliovirus | 0.425815 |
| routine vaccination coverage | 0.501735 |
| FATA | 0.46965 |
| injectable inactivated polio | 0.426947 |
| wild poliovirus type | 0.532035 |
| AFP cases | 0.580743 |
| SIAs | 0.488866 |
| United Nations Children | 0.427447 |
| adequate stool specimens§ | 0.424321 |
| Pakistan | 0.608088 |
| children | 0.523425 |
| immunization activities | 0.435307 |
| WPV1-positive environmental surveillance | 0.434322 |
| national immunization campaign | 0.442456 |
| Balochistan | 0.425539 |
| nonpolio AFP cases | 0.511097 |
| WPV1 cases | 0.915366 |
|
| public health | 0.468963 |
| WPV1 patients | 0.427583 |
| routine immunization services | 0.660717 |
| supplemental immunization activities | 0.429953 |
| period | 0.441114 |
| World Health Organization | 0.61721 |
| South Waziristan | 0.443414 |
| environmental samples | 0.486442 |
| fewer WPV1 lineages | 0.436661 |
| type 2-containing OPV | 0.484673 |
| KP | 0.454469 |
| polio cases | 0.439161 |
| AFP surveillance quality | 0.463521 |
| newly confirmed WPV1 | 0.432281 |
| Emergency Operations Center | 0.491733 |
| acute flaccid paralysis | 0.697791 |
| public health practice | 0.431895 |
| AFP surveillance | 0.718798 |
| stool specimen timeliness | 0.602422 |
| adequate stool | 0.511034 |
| vaccine-derived poliovirus | 0.429116 |
| national routine vaccination | 0.439913 |
| environmental surveillance samples | 0.518952 |
|
CLICK HERE |